[1]BIAZZO A,DE PAOLIS M.Multidisciplinary approach to osteosarcoma[J].Acta Orthop Belg,2016,82:690-698. [br/][2]RITTER J,BIELACK SS.Osteosarcoma[J].Ann Oncol,2010,21(Suppl 7):vii320-325. [br/][3]LIU Y,HUANG N,LIAO S,et al.Current research progress in targeted anti-angiogenesis therapy for osteosarcoma[J].Cell Prolif,2021,54:e13102. [br/][4]SHENG G,GAO Y,YANG Y,et al.Osteosarcoma and metastasis[J].Front Oncol,2021,11:780264. [br/][5]KOVACS D,IGAZ N,KESKENY C,et al.Silver nanoparticles defeat p53-positive and p53-negative osteosarcoma cells by triggering mitochondrial stress and apoptosis[J].Sci Rep,2016,6:27902. [br/][6]YANG Q,WANG Y,YANG Q,et al.Cuprous oxide nanoparticles trigger ER stress-induced apoptosis by regulating copper trafficking and overcoming resistance to sunitinib therapy in renal cancer[J].Biomaterials,2017,146:72-85. [br/][7]CHEN S,XING Z,GENG M,et al.Macrophage fusion event as one prerequisite for inorganic nanoparticle-induced antitumor response[J].Sci Adv,2023,9:eadd9871. [br/][8]KOO S,KIM YG,LEE N,et al.Inorganic nanoparticle agents for enhanced chemodynamic therapy of tumours[J].Nanoscale,2023,15:13498-13514. [br/][9]VAGHARI-TABARI M,JAFARI-GHARABAGHLOU D,MOHAMMADI M,et al.Zinc oxide nanoparticles and cancer chemotherapy:Helpful tools for enhancing chemo-sensitivity and reducing side effects[J]?Biol Trace Elem Res,2024,202:1878-1900. [br/][10]DRREHER MR,LIU W,MICHELICH CR,et al.Tumor vascular permeability,accumulation,and penetration of macromolecular drug carriers[J].J Natl Cancer Inst,2006,98:335-344. [br/][11]BISHT G,RARAMAJHI S.ZnO nanoparticles:A promising anticancer agent[J].Nanobiomedicine,2016,3:9. [br/][12]NG KW,KHOO SP,HENG BC,et al.The role of the tumor suppressor p53 pathway in the cellular DNA damage response to zinc oxide nanoparticles[J].Biomaterials,2011,32:8218-8225. [br/][13]HE G,MA Y,ZHU Y,et al.Cross talk between autophagy and apoptosis contributes to ZnO nanoparticle-induced human osteosarcoma cell death[J].Adv Healthc Mater,2018,7:e1800332. [br/][14]LIU J,KANG Y,YIN S,et al.Zinc oxide nanoparticles induce toxic responses in human neuroblastoma SHSY5Y cells in a size-dependent manner[J].Int J Nanomedicine,2017,12:8085-8099. [br/][15]GU W,YANG C.Zinc oxide nanoparticles mitigate the malignant progression of ovarian cancer by mediating autophagy-dependent ferroptosis[J].J Cancer Res Clin Oncol,2024,150:513. [br/][16]OKKENHAUG K,GRAUPERA M,VANHAESEBROECK B.Targeting PI3K in cancer:Impact on tmor cells,their protective stroma,angiogenesis,and immunotherapy[J].Cancer Discov,2016,6:1090-1105. [br/][17]DENG W,LIU X,HUANG S,et al.CXCL16 promotes tumor metastasis by regulating angiogenesis in the tumor micro-environment of BRAF V600E mutant colorectal cancer[J].Transl Oncol,2024,41:101854. [br/][18]LYU Y,ZHAO X,ZHU L,et al.Targeting intracellular MMPs efficiently inhibits tumor metastasis and angiogenesis[J].Theranostics,2018,8:2830-2845. [br/][19]ZHAO Y,AN M,ZHANG H,et al.Patient-derived bladder cancer xenograft models reveal VEGF and CDK4 enhancing tumor metastasis behavior[J].RSC Adv,2019,9:17877-17884. [br/][20]CHENNG J,HE S,WANG M,et al.The Caspase-3/PKCdelta/Akt/VEGF-A signaling pathway mediates tumor repopulation during radiotherapy[J].Clin Cancer Res,2019,25:3732-3743. [br/][21]CHATTERJEE S,HEUKAMP LC,SIOBAL M,et al.Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancer[J].J Clin Invest,2013,123:1732-1740. [br/][22]POIER N,HOCHSTOGER J,HACKENBERG S,et al.Effects of zinc oxide nanoparticles in HUVEC:Cyto- and genotoxicity and functional impairment after long-term and repetitive exposure in vitro[J].Int J Nanomedicine,2020,15:4441-4452. [br/][23]MOHAMMAD G,TABRIZI MH,ARDAALAN T,et al.synthesis of zinc oxide nanoparticles and evaluation of anti-angiogenesis,anti-inflammatory and cytotoxicity properties[J].J Biosci,2019,2019:44.